Genes like CXCR4 and AURKA are identified as key targets for these regulatory TFs, highlighting their functional significance in IPF pathophysiology (Smadja et al., 2014; Jaffar et al., 2020). The gene discussed is CXCR4; the disease is idiopathic pulmonary fibrosis.